ORIC Competitors & Alternatives
Compare Oric Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ORIC
Main Stock$11.64
Tradestie Score
58
Market Cap
$1.14B
Analyst Upside
+74.3%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PGEN
Precigen, Inc. Common Stock
|
$5.64
|
$1.18B | - | 58 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$49.82
|
$1.17B | - | 61 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$22.31
|
$1.15B | 3.5 | 55 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.93
|
$1.14B | - | 59 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$31.26
|
$1.13B | - | 54 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$6.26
|
$1.12B | - | 52 | Compare |
|
NKTR
Nektar Therapeutics
|
$71.04
|
$1.12B | - | 55 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$318.52
|
$1.12B | - | 58 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.95
|
$1.09B | - | 57 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$13.77
|
$1.05B | 73.5 | 55 | Compare |
More ORIC Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry